Minister Advocates UK as Prime Market for Swift Adoption of Novel Therapies

One author praised the roll-out of the COVID-19 vaccine as a model to be emulated, but a pharma expert warned against a risky technique used during the process.

Director of the Number 10 Policy Unit Andrew Griffith walks outside Downing Street after a COBR meeting, in London on Feb. 22, 2022. Henry Nicholls/Reuters

A government minister has advocated pushing the UK as a primary market for the quicker adoption of novel therapies, pointing towards the British health care system as an integrated model that can help speed up the process.

Speaking on Tuesday, Andrew Griffith, the minister of state for science, research, and innovation, emphasised the pivotal role of health care in government spending, revealing that a substantial proportion was dedicated to the health sector.